Researchers combined deep phenotyping with platelet proteomics in frail older women to characterize how platelet reactivity shifts with frailty status. The work positions clotting behavior as a measurable biological correlate of frailty rather than an incidental comorbidity, with implications for thrombotic and cardiovascular risk stratification in aging populations.
Key Points
- Platelet reactivity profiled alongside frailty phenotype in older women
- Proteomic signatures link clotting behavior to frailty status
- Suggests measurable vascular contribution to frailty-associated risk
Longevity Analysis
Frailty is typically assessed through grip strength, gait speed, and exhaustion — functional outputs that arrive late. Platelet proteomics offers an earlier, molecular read on the same decline, tying how blood moves and clots to how the body holds its structure and recovers from stress. Identifying hyperreactive clotting in frail individuals creates a target: interference from inflammation, sedentary patterns, and metabolic strain can be addressed before thrombotic events force the issue.
Original published by Nature - npj Aging, by Magdalena Sepúlveda.